52W high -19.0%52W low +25.6%Market cap $702,433Avg volume 370
Company Overview
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of GSK plc (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
